potent, bioavailable autotaxin inhibitor

orally active in fibrosis mod., Ph. I IND cleared

from 225M cmpd DNA-encoded library + opt.

J. Med. Chem., Jul. 23, 2020

X-Chem, Waltham, MA

X-165 is an autotaxin inhibitor clinical candidate for idiopathic pulmonary fibrosis discovered using a 3-cycle DEL screen of 225M compounds derived from amide couplings. An unusual spirocyclic amine building block…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks